New hope for tough gout cases: trial tests Next-Line treatment
NCT ID NCT07116746
Summary
This study is testing a new combination of medications (AR882 with a standard drug) for people with severe, uncontrolled gout. It's specifically for those whose gout did not improve or who had bad reactions to a previous strong treatment called uricase. The main goals are to see if this new approach can lower uric acid levels in the blood and reduce painful, chalky lumps called tophi.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERURICEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Arthrosi Investigative Site (102)
RECRUITINGMiami, Florida, 33155, United States
-
Arthrosi Investigative Site (103)
RECRUITINGDuncansville, Pennsylvania, 16635, United States
-
Arthrosi Investigative Site (104)
RECRUITINGWest Lake Hills, Texas, 78746, United States
-
Arthrosi Investigative Site (105)
RECRUITINGMargate, Florida, 33063, United States
-
Arthrosi Investigative Site (106)
RECRUITINGJackson, Mississippi, 39202, United States
-
Arthrosi Investigative Site (107)
RECRUITINGBellevue, Washington, 98004, United States
-
Arthrosi Investigative Site (108)
RECRUITINGCharlotte, North Carolina, 28202, United States
-
Arthrosi Investigative Site (109)
RECRUITINGTampa, Florida, 33609, United States
Conditions
Explore the condition pages connected to this study.